Cover Image

Screening for inhibitors against SARS-CoV-2 and its variants

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to evolve, generating new variants that pose a threat to global health; therefore, it is imperative to obtain safe and broad-spectrum antivirals against SARS-CoV-2 and its variants. To this end, we screened compounds for their ab...

Full description

Saved in:

Bibliographic Details
Main Authors:	Weijing Yuan (Author), Xiaojing Dong (Author), Lan Chen (Author), Xiaobo Lei (Author), Zhuo Zhou (Author), Li Guo (Author), Jianwei Wang (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants
by: Waseem Ahmad Ansari, et al.
Published: (2022)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants
by: Bin Tu, et al.
Published: (2022)

Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study
by: Hu Wang, et al.
Published: (2022)

Leveraging immunoliposomes as nanocarriers against SARS-CoV-2 and its emerging variants
by: Nur Dini Fatini Mohammad Faizal, et al.
Published: (2023)

Neutralization of ARCoV-induced sera against SARS-CoV-2 variants
by: Xiao-Feng Li, et al.
Published: (2022)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022)

Booster COVID-19 vaccination against the SARS-CoV-2 Omicron variant: A systematic review
by: Yuxuan Du, et al.
Published: (2022)

Screening of a Small Molecule Compound Library Identifies Toosendanin as an Inhibitor Against Bunyavirus and SARS-CoV-2
by: Shufen Li, et al.
Published: (2021)

Decoding the next SARS-CoV-2 variant
by: Jeremy Nel, et al.
Published: (2022)

Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase
by: Quanjie Li, et al.
Published: (2021)

Folic acid: a potential inhibitor against SARS-CoV-2 nucleocapsid protein
by: Yu-meng Chen, et al.
Published: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022)

Would New SARS-CoV-2 Variants Change the War against COVID-19?
by: Elrashdy M. Redwan, et al.
Published: (2022)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Heterologous BBIBP-CorV/ZF2001 vaccination augments neutralization against SARS-CoV-2 variants: A preliminary observation
by: Yingze Zhao, et al.
Published: (2022)

Recent advances in developing small-molecule inhibitors against SARS-CoV-2
by: Rong Xiang, et al.
Published: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022)

The Emergence and Spread of Novel SARS-CoV-2 Variants
by: Huaimin Yi, et al.
Published: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants
by: Ying Guo, et al.
Published: (2022)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

In Silico Therapeutic Study: The Next Frontier in the Fight against SARS-CoV-2 and Its Variants
by: Calvin R. Wei, et al.
Published: (2024)

Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
by: Renhui Dai, et al.
Published: (2023)

Nucleotide analogues as inhibitors of SARS‐CoV Polymerase
by: Jingyue Ju, et al.
Published: (2020)

A trimeric spike-based COVID-19 vaccine candidate induces broad neutralization against SARS-CoV-2 variants
by: Feixia Gao, et al.
Published: (2023)

Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
by: Qianqian Cui, et al.
Published: (2023)

Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study
by: Yun Yin, et al.
Published: (2023)

Different SARS-CoV-2 variants, same prevention strategies
by: Tafadzwa Dzinamarira, et al.
Published: (2022)

Genetic variants of SARS-CoV-2 and its clinical implications
by: Alexander Expósito Lara, et al.
Published: (2021)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022)

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
by: Shiu-Wan Chan
Published: (2022)

Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
by: Cong Liu, et al.
Published: (2022)

Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2
by: Hualou Liang, et al.
Published: (2021)

The Integration of Pharmacophore-Based 3D-QSAR Modeling and Virtual Screening in Identification of Natural Product Inhibitors against SARS-CoV-2
by: Samira Norouzi, et al.
Published: (2021)

Management of SARS-CoV-2 Omicron Variant Community Screenings in Shanghai, China: A Cross-Sectional Study
by: Chen K, et al.
Published: (2023)

Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease
by: Palla Ramprasad, et al.
Published: (2022)

Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants
by: Zhe Ding, et al.
Published: (2022)